Literature DB >> 2200861

Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.

R Jalil1, J R Nixon.   

Abstract

Poly(lactic acid) [PLA] and its co-polymers with glycolic acid [PLCG] have been known to be biodegradable and histocompatible for the past 20 years. Their physico-chemical and biological properties have been found suitable, in many instances, for sustaining drug release in vivo for days or months. Several dosage forms for parenteral administration have been investigated using these polymers and a microencapsulation technique is chosen frequently for its unique properties. There are a limited number of published papers concerning preparation and characterization of PLA or PLCG microcapsules, possibly because of commercial unavailability and difficulties in the synthesis of reproducible batches of these polymers. However, microcapsules can be made using different traditional and non-traditional techniques containing core materials ranging from biological proteins to synthetic drugs. An attempt is made here to review problems associated with the different microencapsulation techniques using PLA or PLCG. In vivo and in vitro drug release from these microcapsules is also reviewed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200861     DOI: 10.3109/02652049009021842

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  35 in total

1.  Online monitoring of PLGA microparticles formation using Lasentec focused beam reflectance (FBRM) and particle video microscope (PVM).

Authors:  Ahmed S Zidan; Ziyaur Rahman; Mansoor A Khan
Journal:  AAPS J       Date:  2010-03-30       Impact factor: 4.009

2.  Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.

Authors:  S Takada; T Kurokawa; K Miyazaki; S Iwasa; Y Ogawa
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 3.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

4.  In vitro and in vivo drug release from a novel in situ forming drug delivery system.

Authors:  Heiko Kranz; Erol Yilmaz; Gayle A Brazeau; Roland Bodmeier
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

5.  Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.

Authors:  Chunqiang Guo; Richard A Gemeinhart
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

Review 6.  Points to consider when establishing drug product specifications for parenteral microspheres.

Authors:  Rajesh Kumar; Michael J Palmieri
Journal:  AAPS J       Date:  2009-11-17       Impact factor: 4.009

7.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

Review 8.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

9.  High bioavailabilty of alpha-tocopherol loaded into poly (DL-lactic-co-glycolic acid) microspheres in apolipoprotein B knockout mice.

Authors:  Koichi Yokogawa; Yuichiro Shima; Tomoka Hashimoto; Makoto Hiyajyo; Kaori Kadoyama; Junko Ishizaki; Masaaki Nomura; Ken-ichi Miyamoto
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

10.  Prolonging the in vivo residence time of prostaglandin E(1) with biodegradable nanoparticles.

Authors:  Tsutomu Ishihara; Miyuki Takahashi; Megumu Higaki; Mitsuko Takenaga; Tohru Mizushima; Yutaka Mizushima
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.